# Daily evaluation — 2026-10-19 ~20:30 UTC

## Scope

Scheduled weekday mechanism check. Not a trading-strategy review — that's
the evolution process's job, not this one.

## Did today's trading go smoothly?

Yes. Tick 66 (`runs/2026-10-19-0020-daily-trading.md`, ~00:22 UTC):

- Bar 2026-10-18, NAV $14,459.00 → $14,439.15, cash $5,053.89 → $5,064.99.
- Bought NEARUSDT and DOTUSDT via `consult_moderate`'s confirmed-trend
  signal, approved by `superior_judge`. Position book after: AAVEUSDT,
  FILUSDT, ATOMUSDT, INJUSDT, NEARUSDT, DOTUSDT.
- `66 % 7 == 3`, so no `evolve` call as part of the tick — correct per
  schedule.
- No hard call flagged this tick. `review-hard-calls` backlog unchanged (6
  reviewed, 0 pending).
- Genome unchanged at v3 (live champion since 2026-08-16). Account not
  halted. Constitution verified `726dfa4bac85891a`, no modification
  detected.
- Container started in detached HEAD, 51 commits behind; `git checkout
  main` + `git pull --rebase` fast-forwarded cleanly — the documented
  shallow-clone-staleness pattern, not a real divergence. The recurring
  `pip3` vs `python3 -m pip` numpy/pandas split recurred and was fixed the
  usual way.

No mechanism errors, near-misses, or surprises in today's daily trading run.

## Rest of today's activity

Five more 15-generation `evolve` batches ran against the live v3 champion
today via the 3-hourly-check cadence (~01:24, ~04:27, ~07:27, ~10:23,
~13:30, ~16:32, ~19:17 UTC — seven total including the ones already covered
by the 09:00 daily discussion), plus the 09:00 UTC daily discussion itself.
None promoted. Cumulative candidates tried against v3 rose from 72,876 at
yesterday's last check to **74,320** by ~19:17 UTC
(`researcher_memory.tested`), stagnation/boldness counter 5,258 → 5,378.
Champion's fold-aggregate fitness held flat at 0.997 throughout the day's
final batches (975 trades, 37% win, 1% stops, 4 halts, unchanged). Each
batch was verified before commit per the established discipline: full test
suite green both before and after, `live_state.json` top-level diff limited
to `updated`/`researcher_memory`/`lineage` (genome/broker/journal/
hard_call_reviews byte-identical), `tools/edit_bundle_module.py
verify`/`sync --check` clean, `holdout-pressure` re-checked read-only
(margin crept 7.607 → 7.622, draw count 1,386 → 1,425 — all new draws
correctly rejected sealed-holdout clearers, the same slow expected rise item
13 tracks).

Current `live_state.json` state as of this evaluation: genome v3, not
halted, NAV history last entry $14,459.00 (2026-10-18 bar), cash
$5,064.99 cash, 6 open positions, 6 hard-call reviews (0 pending),
researcher_memory tested=74,320 / stagnation=5,378 / holdout_draws=1,425 —
all consistent with the last evolve batch's own run note.

## Mechanism assessment

Nothing to flag. No errors, no unexpected `CONSTITUTION MODIFIED` reports,
no git divergence beyond the routine shallow-clone staleness (handled
cleanly), no item-9-style backgrounding mistakes in any of today's batches.
`AGENTS.md` is 236,829 bytes — comfortably under the 256KB single-read
threshold (last rotated 2026-10-18 ~15:46 UTC), no rotation needed today.
Items 6 and 13 under "Owner decisions pending" remain open and unchanged,
with no new trigger — item 13's margin growth (7.607 → 7.622 today, ~0.015)
is in line with the 2026-10-10 design pass's "genuinely mild" projection.

No "Next steps" additions from this evaluation — nothing new surfaced
beyond the already-tracked, already-documented items.

## Conclusion

Today went smoothly: one clean daily trading tick, seven clean evolve
batches, no promotions, no mechanism faults. Nothing needs the owner's
attention beyond the two already-open, already-surfaced items (6 and 13),
neither of which has a new trigger today.
